Trademark: 97271397
Status Date
Wednesday, March 27, 2024
Filing Date
Thursday, February 17, 2022
Published for Opposition
Tuesday, February 14, 2023
5 Pharmaceutical products for the treatment of cancer, all of the foregoing excluding pharmaceutical products for sleep disorders, central nervous disorders other than cancers of the central nervous system, and neurological disorders other than cancers of the neurological system
Mar 28, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 27, 2024
Sou Extension 2 Granted
Mar 27, 2024
Sou Extension 2 Filed
Mar 27, 2024
Sou Teas Extension Received
Feb 27, 2024
Teas Change Of Correspondence Received
Feb 27, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 27, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 3, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 29, 2023
Sou Extension 1 Granted
Sep 29, 2023
Sou Extension 1 Filed
Sep 29, 2023
Sou Teas Extension Received
Jun 27, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 27, 2023
Case Assigned To Intent To Use Paralegal
May 5, 2023
Teas Post Publication Amendment Received
Apr 11, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 14, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 14, 2023
Published For Opposition
Jan 25, 2023
Notification Of Notice Of Publication E-Mailed
Jan 10, 2023
Approved For Pub - Principal Register
Jan 10, 2023
Examiner's Amendment Entered
Jan 10, 2023
Notification Of Examiners Amendment E-Mailed
Jan 10, 2023
Examiners Amendment E-Mailed
Jan 10, 2023
Examiners Amendment -Written
Jan 9, 2023
Previous Allowance Count Withdrawn
Dec 20, 2022
Withdrawn From Pub - Og Review Query
Dec 7, 2022
Approved For Pub - Principal Register
Dec 2, 2022
Notification Of Letter Of Suspension E-Mailed
Dec 2, 2022
Letter Of Suspension E-Mailed
Dec 2, 2022
Suspension Letter Written
Dec 2, 2022
Assigned To Examiner
Feb 23, 2022
New Application Office Supplied Data Entered
Feb 21, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
